Clinical and organizational management of cardiac implantable electronic device replacements

Autor: Maurizio Landolina, Luca Santini, Giuseppe Boriani, Massimo Zoni Berisso, Antonio Rapacciuolo, Pietro Palmisano, Giuseppina Belotti, Giuseppe Stabile, Renato Pietro Ricci, Roberto De Ponti, Matteo Ziacchi
Přispěvatelé: Palmisano, Pietro, Ziacchi, Matteo, Belotti, Giuseppina, Rapacciuolo, Antonio, Santini, Luca, Stabile, Giuseppe, Zoni Berisso, Massimo, De Ponti, Roberto, Landolina, Maurizio, Ricci, Renato, Boriani, Giuseppe
Rok vydání: 2019
Předmět:
Pacemaker
Artificial

medicine.medical_specialty
Time Factors
implantable cardioverter defibrillator
Cardiac pacing
Electric Countershock
cardiac resynchronization therapy
cardiac implantable electronic device
Italian Association of Arrhythmology and Cardiac Pacing survey
pacemaker
replacement
030204 cardiovascular system & hematology
Drug Administration Schedule
03 medical and health sciences
Patient Admission
0302 clinical medicine
Humans
Medicine
030212 general & internal medicine
Practice Patterns
Physicians'

Intensive care medicine
Device Removal
business.industry
Cardiac Pacing
Artificial

Anticoagulants
Health Care Costs
General Medicine
Antibiotic Prophylaxis
Length of Stay
Defibrillators
Implantable

Prosthesis Failure
Treatment Outcome
Ambulatory Surgical Procedures
Italy
Health Care Surveys
Organizational management
Cardiology and Cardiovascular Medicine
business
Zdroj: Journal of Cardiovascular Medicine. 20:531-541
ISSN: 1558-2027
DOI: 10.2459/jcm.0000000000000817
Popis: The aim of this survey was to assess the management and organization of cardiac implantable electronic device (CIED) replacement in Italy.A questionnaire consisting of 24 questions on organizational aspects and on the peri-procedural management of anticoagulant therapies and antibiotic prophylaxis was sent via the Internet to 154 Italian arrhythmia centers.A total of 103 out of 154 centers completed the questionnaire (67% response rate). In 43% of the centers, the procedures were performed under day-case admission, in 40% under ordinary admission, and in 17% under either day-case or ordinary admission. The most frequent reason (66%) for choosing ordinary admission rather than day-case admission was to obtain full reimbursement. Although warfarin therapy was continued in 73% of the centers, nonvitamin K oral anticoagulants were discontinued, without bridging, 24 h or less prior to replacement procedures in 88%. Prophylactic antibiotic therapy was systematically administered in all centers; in 97%, the first antibiotic dose was administered 1-2 h prior to procedures. Local antibacterial envelopes were also used in 43% of the centers in patients with a higher risk of device infection.This survey provides a representative picture of how CIED replacements are organized and managed in current Italian clinical practice. The choice of the type of hospitalization (short versus ordinary) was more often motivated by economic reasons (reimbursement of the procedure) than by clinical and organizational factors. Peri-procedural management of anticoagulation and prophylactic antibiotic therapy was consistent with current scientific evidence.
Databáze: OpenAIRE